Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Drug Screening Laboratory Services Market

ID: MRFR/MRO/64733-HCR
200 Pages
Shubham Munde
Last Updated: April 24, 2026

Drug Screening Laboratory Services Market Size, Share and Trends Analysis Research Report Information By End Use (Pharmaceutical Companies, Hospitals, Rehabilitation Centers, Government Agencies), By Application (Workplace Drug Testing, Clinical Drug Testing, Forensic Drug Testing, Home Drug Testing), By Sample Type (Urine, Blood, Saliva, Hair), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Drug Screening Laboratory Services Market Infographic
Purchase Options
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Food, Beverages & Nutrition, BY Application (USD Billion) | |
      1. 4.1.1 Workplace Drug Testing | |
      2. 4.1.2 Clinical Drug Testing | |
      3. 4.1.3 Forensic Drug Testing | |
      4. 4.1.4 Home Drug Testing |
    2. 4.2 Food, Beverages & Nutrition, BY Sample Type (USD Billion) | |
      1. 4.2.1 Urine | |
      2. 4.2.2 Blood | |
      3. 4.2.3 Saliva | |
      4. 4.2.4 Hair |
    3. 4.3 Food, Beverages & Nutrition, BY End Use (USD Billion) | |
      1. 4.3.1 Pharmaceutical Companies | |
      2. 4.3.2 Hospitals | |
      3. 4.3.3 Rehabilitation Centers | |
      4. 4.3.4 Government Agencies |
    4. 4.4 Food, Beverages & Nutrition, BY Region (USD Billion) | |
      1. 4.4.1 North America | | |
        1. 4.4.1.1 US | | |
        2. 4.4.1.2 Canada | |
      2. 4.4.2 Europe | | |
        1. 4.4.2.1 Germany | | |
        2. 4.4.2.2 UK | | |
        3. 4.4.2.3 France | | |
        4. 4.4.2.4 Russia | | |
        5. 4.4.2.5 Italy | | |
        6. 4.4.2.6 Spain | | |
        7. 4.4.2.7 Rest of Europe | |
      3. 4.4.3 APAC | | |
        1. 4.4.3.1 China | | |
        2. 4.4.3.2 India | | |
        3. 4.4.3.3 Japan | | |
        4. 4.4.3.4 South Korea | | |
        5. 4.4.3.5 Malaysia | | |
        6. 4.4.3.6 Thailand | | |
        7. 4.4.3.7 Indonesia | | |
        8. 4.4.3.8 Rest of APAC | |
      4. 4.4.4 South America | | |
        1. 4.4.4.1 Brazil | | |
        2. 4.4.4.2 Mexico | | |
        3. 4.4.4.3 Argentina | | |
        4. 4.4.4.4 Rest of South America | |
      5. 4.4.5 MEA | | |
        1. 4.4.5.1 GCC Countries | | |
        2. 4.4.5.2 South Africa | | |
        3. 4.4.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 LabCorp (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Quest Diagnostics (US) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Thermo Fisher Scientific (US) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Abbott Laboratories (US) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 MedTox Scientific (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Alere (US) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Psychemedics Corporation (US) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Roche Diagnostics (CH) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies | |
      9. 5.2.9 Siemens Healthineers (DE) | | |
        1. 5.2.9.1 Financial Overview | | |
        2. 5.2.9.2 Products Offered | | |
        3. 5.2.9.3 Key Developments | | |
        4. 5.2.9.4 SWOT Analysis | | |
        5. 5.2.9.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY APPLICATION |
    7. 6.4 US MARKET ANALYSIS BY SAMPLE TYPE |
    8. 6.5 US MARKET ANALYSIS BY END USE |
    9. 6.6 CANADA MARKET ANALYSIS BY APPLICATION |
    10. 6.7 CANADA MARKET ANALYSIS BY SAMPLE TYPE |
    11. 6.8 CANADA MARKET ANALYSIS BY END USE |
    12. 6.9 EUROPE MARKET ANALYSIS |
    13. 6.10 GERMANY MARKET ANALYSIS BY APPLICATION |
    14. 6.11 GERMANY MARKET ANALYSIS BY SAMPLE TYPE |
    15. 6.12 GERMANY MARKET ANALYSIS BY END USE |
    16. 6.13 UK MARKET ANALYSIS BY APPLICATION |
    17. 6.14 UK MARKET ANALYSIS BY SAMPLE TYPE |
    18. 6.15 UK MARKET ANALYSIS BY END USE |
    19. 6.16 FRANCE MARKET ANALYSIS BY APPLICATION |
    20. 6.17 FRANCE MARKET ANALYSIS BY SAMPLE TYPE |
    21. 6.18 FRANCE MARKET ANALYSIS BY END USE |
    22. 6.19 RUSSIA MARKET ANALYSIS BY APPLICATION |
    23. 6.20 RUSSIA MARKET ANALYSIS BY SAMPLE TYPE |
    24. 6.21 RUSSIA MARKET ANALYSIS BY END USE |
    25. 6.22 ITALY MARKET ANALYSIS BY APPLICATION |
    26. 6.23 ITALY MARKET ANALYSIS BY SAMPLE TYPE |
    27. 6.24 ITALY MARKET ANALYSIS BY END USE |
    28. 6.25 SPAIN MARKET ANALYSIS BY APPLICATION |
    29. 6.26 SPAIN MARKET ANALYSIS BY SAMPLE TYPE |
    30. 6.27 SPAIN MARKET ANALYSIS BY END USE |
    31. 6.28 REST OF EUROPE MARKET ANALYSIS BY APPLICATION |
    32. 6.29 REST OF EUROPE MARKET ANALYSIS BY SAMPLE TYPE |
    33. 6.30 REST OF EUROPE MARKET ANALYSIS BY END USE |
    34. 6.31 APAC MARKET ANALYSIS |
    35. 6.32 CHINA MARKET ANALYSIS BY APPLICATION |
    36. 6.33 CHINA MARKET ANALYSIS BY SAMPLE TYPE |
    37. 6.34 CHINA MARKET ANALYSIS BY END USE |
    38. 6.35 INDIA MARKET ANALYSIS BY APPLICATION |
    39. 6.36 INDIA MARKET ANALYSIS BY SAMPLE TYPE |
    40. 6.37 INDIA MARKET ANALYSIS BY END USE |
    41. 6.38 JAPAN MARKET ANALYSIS BY APPLICATION |
    42. 6.39 JAPAN MARKET ANALYSIS BY SAMPLE TYPE |
    43. 6.40 JAPAN MARKET ANALYSIS BY END USE |
    44. 6.41 SOUTH KOREA MARKET ANALYSIS BY APPLICATION |
    45. 6.42 SOUTH KOREA MARKET ANALYSIS BY SAMPLE TYPE |
    46. 6.43 SOUTH KOREA MARKET ANALYSIS BY END USE |
    47. 6.44 MALAYSIA MARKET ANALYSIS BY APPLICATION |
    48. 6.45 MALAYSIA MARKET ANALYSIS BY SAMPLE TYPE |
    49. 6.46 MALAYSIA MARKET ANALYSIS BY END USE |
    50. 6.47 THAILAND MARKET ANALYSIS BY APPLICATION |
    51. 6.48 THAILAND MARKET ANALYSIS BY SAMPLE TYPE |
    52. 6.49 THAILAND MARKET ANALYSIS BY END USE |
    53. 6.50 INDONESIA MARKET ANALYSIS BY APPLICATION |
    54. 6.51 INDONESIA MARKET ANALYSIS BY SAMPLE TYPE |
    55. 6.52 INDONESIA MARKET ANALYSIS BY END USE |
    56. 6.53 REST OF APAC MARKET ANALYSIS BY APPLICATION |
    57. 6.54 REST OF APAC MARKET ANALYSIS BY SAMPLE TYPE |
    58. 6.55 REST OF APAC MARKET ANALYSIS BY END USE |
    59. 6.56 SOUTH AMERICA MARKET ANALYSIS |
    60. 6.57 BRAZIL MARKET ANALYSIS BY APPLICATION |
    61. 6.58 BRAZIL MARKET ANALYSIS BY SAMPLE TYPE |
    62. 6.59 BRAZIL MARKET ANALYSIS BY END USE |
    63. 6.60 MEXICO MARKET ANALYSIS BY APPLICATION |
    64. 6.61 MEXICO MARKET ANALYSIS BY SAMPLE TYPE |
    65. 6.62 MEXICO MARKET ANALYSIS BY END USE |
    66. 6.63 ARGENTINA MARKET ANALYSIS BY APPLICATION |
    67. 6.64 ARGENTINA MARKET ANALYSIS BY SAMPLE TYPE |
    68. 6.65 ARGENTINA MARKET ANALYSIS BY END USE |
    69. 6.66 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
    70. 6.67 REST OF SOUTH AMERICA MARKET ANALYSIS BY SAMPLE TYPE |
    71. 6.68 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE |
    72. 6.69 MEA MARKET ANALYSIS |
    73. 6.70 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION |
    74. 6.71 GCC COUNTRIES MARKET ANALYSIS BY SAMPLE TYPE |
    75. 6.72 GCC COUNTRIES MARKET ANALYSIS BY END USE |
    76. 6.73 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION |
    77. 6.74 SOUTH AFRICA MARKET ANALYSIS BY SAMPLE TYPE |
    78. 6.75 SOUTH AFRICA MARKET ANALYSIS BY END USE |
    79. 6.76 REST OF MEA MARKET ANALYSIS BY APPLICATION |
    80. 6.77 REST OF MEA MARKET ANALYSIS BY SAMPLE TYPE |
    81. 6.78 REST OF MEA MARKET ANALYSIS BY END USE |
    82. 6.79 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION |
    83. 6.80 RESEARCH PROCESS OF MRFR |
    84. 6.81 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION |
    85. 6.82 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION |
    86. 6.83 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION |
    87. 6.84 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION |
    88. 6.85 FOOD, BEVERAGES & NUTRITION, BY APPLICATION, 2024 (% SHARE) |
    89. 6.86 FOOD, BEVERAGES & NUTRITION, BY APPLICATION, 2024 TO 2035 (USD Billion) |
    90. 6.87 FOOD, BEVERAGES & NUTRITION, BY SAMPLE TYPE, 2024 (% SHARE) |
    91. 6.88 FOOD, BEVERAGES & NUTRITION, BY SAMPLE TYPE, 2024 TO 2035 (USD Billion) |
    92. 6.89 FOOD, BEVERAGES & NUTRITION, BY END USE, 2024 (% SHARE) |
    93. 6.90 FOOD, BEVERAGES & NUTRITION, BY END USE, 2024 TO 2035 (USD Billion) |
    94. 6.91 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    95. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    96. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.2.3 BY END USE, 2025-2035 (USD Billion) |
    97. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.3.3 BY END USE, 2025-2035 (USD Billion) |
    98. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.4.3 BY END USE, 2025-2035 (USD Billion) |
    99. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.5.3 BY END USE, 2025-2035 (USD Billion) |
    100. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.6.3 BY END USE, 2025-2035 (USD Billion) |
    101. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.7.3 BY END USE, 2025-2035 (USD Billion) |
    102. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.8.3 BY END USE, 2025-2035 (USD Billion) |
    103. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.9.3 BY END USE, 2025-2035 (USD Billion) |
    104. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.10.3 BY END USE, 2025-2035 (USD Billion) |
    105. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.11.3 BY END USE, 2025-2035 (USD Billion) |
    106. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.12.3 BY END USE, 2025-2035 (USD Billion) |
    107. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.13.3 BY END USE, 2025-2035 (USD Billion) |
    108. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.14.3 BY END USE, 2025-2035 (USD Billion) |
    109. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.15.3 BY END USE, 2025-2035 (USD Billion) |
    110. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.16.3 BY END USE, 2025-2035 (USD Billion) |
    111. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.17.3 BY END USE, 2025-2035 (USD Billion) |
    112. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.18.3 BY END USE, 2025-2035 (USD Billion) |
    113. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.19.3 BY END USE, 2025-2035 (USD Billion) |
    114. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.20.3 BY END USE, 2025-2035 (USD Billion) |
    115. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.21.3 BY END USE, 2025-2035 (USD Billion) |
    116. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.22.3 BY END USE, 2025-2035 (USD Billion) |
    117. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.23.3 BY END USE, 2025-2035 (USD Billion) |
    118. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.24.3 BY END USE, 2025-2035 (USD Billion) |
    119. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.25.3 BY END USE, 2025-2035 (USD Billion) |
    120. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.26.3 BY END USE, 2025-2035 (USD Billion) |
    121. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.27.3 BY END USE, 2025-2035 (USD Billion) |
    122. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.28.3 BY END USE, 2025-2035 (USD Billion) |
    123. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.29.3 BY END USE, 2025-2035 (USD Billion) |
    124. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      3. 7.30.3 BY END USE, 2025-2035 (USD Billion) |
    125. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    126. 7.32 ACQUISITION/PARTNERSHIP | |

Food, Beverages & Nutrition Market Segmentation

Food, Beverages & Nutrition By Application (USD Billion, 2025-2035)

  • Workplace Drug Testing
  • Clinical Drug Testing
  • Forensic Drug Testing
  • Home Drug Testing

Food, Beverages & Nutrition By Sample Type (USD Billion, 2025-2035)

  • Urine
  • Blood
  • Saliva
  • Hair

Food, Beverages & Nutrition By End Use (USD Billion, 2025-2035)

  • Pharmaceutical Companies
  • Hospitals
  • Rehabilitation Centers
  • Government Agencies

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions